MEDIFAST INC
For the period ended Dec 31, 2024. Filed Feb 18, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 18, 2025
MED$13.37+4.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Stockholders’ Equity
| Numberof SharesIssued | CommonStock | AdditionalPaid-InCapital | AccumulatedOtherComprehensiveIncome (Loss) | RetainedEarnings | TreasuryStock | Total | |
|---|---|---|---|---|---|---|---|
| Balance, January 1, 2022 | 11,594 | $12 | $12,018 | $111 | $190,333 | $— | $202,474 |
| Net income | — | — | — | — | 143,568 | — | 143,568 |
| Share-based compensation | 20 | — | 11,053 | — | — | — | 11,053 |
| Net shares repurchased for taxes | (9) | — | (1,516) | — | — | — | (1,516) |
| Treasury stock from stock repurchases | — | — | — | — | — | (126,445) | (126,445) |
| Treasury stock retired from stock repurchases | (677) | (1) | — | — | (120,047) | 120,047 | (1) |
| Other comprehensive loss | — | — | — | (87) | — | — | (87) |
| Cash dividends declared to stockholders | — | — | — | — | (74,002) | — | (74,002) |
| Balance, December 31, 2022 | 10,928 | $11 | $21,555 | $24 | $139,852 | $(6,398) | $155,044 |
| Net income | — | — | — | — | 99,415 | — | 99,415 |
| Share-based compensation | 76 | — | 8,188 | — | — | — | 8,188 |
| Options exercised by executives and directors | 7 | — | 188 | — | — | — | 188 |
| Net shares repurchased for taxes | (31) | — | (3,358) | — | — | — | (3,358) |
| Treasury stock from stock repurchases | — | — | — | — | — | (3,602) | (3,602) |
| Treasury stock retired from stock repurchases | (84) | — | — | — | (10,000) | 10,000 | — |
| Other comprehensive income | — | — | — | 224 | — | — | 224 |
| Cash dividends declared to stockholders | — | — | — | — | (54,618) | — | (54,618) |
| Balance, December 31, 2023 | 10,896 | $11 | $26,573 | $248 | $174,649 | $— | $201,481 |
| Net income | — | — | — | — | 2,091 | — | 2,091 |
| Share-based compensation | 60 | — | 7,363 | — | — | — | 7,363 |
| Options exercised by directors | 1 | — | 36 | — | — | — | 36 |
| Net shares repurchased for taxes | (19) | — | (836) | — | — | — | (836) |
| Other comprehensive loss | — | — | — | (68) | — | — | (68) |
| Forfeiture of dividends on unvested awards | — | — | — | — | 42 | — | 42 |
| Balance, December 31, 2024 | 10,938 | $11 | $33,136 | $180 | $176,782 | $— | $210,109 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.